Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research methodology PART 04: Introduction • Peripheral vascular stents PART 05: Market landscape • Market overview PART 06: Five forces analysis PART 07: Market segmentation by product • Global self-expanding peripheral vascular stents market • Global balloon-expanding peripheral vascular stents market • Global drug-eluting peripheral vascular stents market PART 08: Market segmentation by end-user • Hospitals • ASCs • Cath labs PART 09: Geographical segmentation • Peripheral vascular stents market in Americas • Peripheral vascular stents market in EMEA • Peripheral vascular stents market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Market challenges PART 12: Market trends • Technology caters the pace for advances in stenting • Emergence of bioabsorbable stents • New product launches and ongoing clinical trials PART 13: Vendor landscape • Competitive scenario PART 14: Key vendor analysis • Boston Scientific • Abbott • Medtronic • Cook • C. R. Bard • BIOTRONIK • Cordis (a Cardinal Health company) • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Share of stents usage in different peripheral arteries 2016 (%) Exhibit 02: Global peripheral vascular stents market 2016-2021 ($ millions) Exhibit 03: Five forces analysis Exhibit 04: Global peripheral vascular stents market by product Exhibit 05: Global peripheral vascular stents market by product 2016 and 2021 (%) Exhibit 06: Global peripheral vascular stents market analysis by product Exhibit 07: Global peripheral vascular stents market by product 2016 and 2021 ($ millions) Exhibit 08: Global peripheral vascular stents market by product 2016-2021 ($ millions) Exhibit 09: Global peripheral vascular stents market by product 2016-2021 (%) Exhibit 10: Global self-expanding peripheral vascular stents market 2016-2021 ($ millions) Exhibit 11: Global balloon-expanding peripheral vascular stents market 2016-2021 ($ millions) Exhibit 12: Global drug-eluting peripheral vascular stents market 2016-2021 ($ millions) Exhibit 13: Global peripheral vascular stents market by end-users 2016 Exhibit 14: Global peripheral vascular stents market by geography 2016 (%) Exhibit 15: Global peripheral vascular stents market by geography 2021 (%) Exhibit 16: Global peripheral vascular stents market by geography 2016 and 2021 (%) Exhibit 17: Global peripheral vascular stents market by geography 2016 and 2021 ($ millions) Exhibit 18: Global peripheral vascular stents market analysis by geography 2016 Exhibit 19: Peripheral vascular stents market in Americas 2016-2021 ($ millions) Exhibit 20: Peripheral vascular stents market in EMEA 2016-2021 ($ millions) Exhibit 21: Peripheral vascular stents market in APAC 2016-2021 ($ millions) Exhibit 22: Global peripheral vascular stents market by geography 2016-2021 ($ millions) Exhibit 23: Global peripheral vascular stents market by geography 2016-2021 (%) Exhibit 24: New product launches 2015-2016 Exhibit 25: Various active ongoing clinical studies on peripheral vascular stents Exhibit 26: Competitive structure analysis of global peripheral vascular stents market 2016 Exhibit 27: Market share of vendors in global peripheral vascular stents market 2016 Exhibit 28: Leading vendors ranking in global peripheral vascular stents market 2016 Exhibit 29: Boston Scientific: Key highlights Exhibit 30: Boston Scientific: Strength assessment Exhibit 31: Boston Scientific: Strategy assessment Exhibit 32: Boston Scientific: Opportunity assessment Exhibit 33: Abbott: Key highlights Exhibit 34: Abbott: Strength assessment Exhibit 35: Abbott: Strategy assessment Exhibit 36: Abbott: Opportunity assessment Exhibit 37: Medtronic: Key highlights Exhibit 38: Medtronic: Strength assessment Exhibit 39: Medtronic: Strategy assessment Exhibit 40: Medtronic: Opportunity assessment Exhibit 41: Cook: Key highlights Exhibit 42: Cook: Strength assessment Exhibit 43: Cook: Strategy assessment Exhibit 44: Cook: Opportunity assessment Exhibit 45: C. R. Bard: Key highlights Exhibit 46: C. R. Bard: Strength assessment Exhibit 47: C. R. Bard: Strategy assessment Exhibit 48: C. R. Bard: Opportunity assessment Exhibit 49: BIOTRONIK: Key highlights Exhibit 50: BIOTRONIK: Strength assessment Exhibit 51: BIOTRONIK: Strategy assessment Exhibit 52: BIOTRONIK: Opportunity assessment Exhibit 53: Cordis: Key highlights Exhibit 54: Cordis: Strength assessment Exhibit 55: Cordis: Strategy assessment Exhibit 56: Cordis: Opportunity assessment

Boston Scientific, Abbott, Medtronic, Cook, C. R. Bard, BIOTRONIK, Cordis (a Cardinal Health company), 480 Biomedical, Alvimedica, B. Braun Melsungen, Balton, Bentley, Biosensors International Group, ENDOCOR, eucatech, InSitu Technologies, InspireMD, iVascular, KYOTO MEDICAL PLANNING, Meril Life Sciences, optimed, PanMed US, RONTIS, Terumo Medical, Veryan Medical, and W. L. Gore & Associates.